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We demonstrated functional associations between mouse adenovirus type 1 (MAV-1) early region 1A (E1A) protein and
both the mouse retinoblastoma protein (pRb) and the mouse pRb-related protein, p107. Interactions between MAV-1 E1A
and mouse pRb or mouse p107 proteins were examined in infected cell lysates using a mouse embryonic fibroblast cell
line infected with wild-type and mutant MAV-1 viruses. Using a polyclonal antibody to MAV-1 E1A, exogenously added
mouse pRb or mouse p107 was coimmunoprecipitated from wild-type-, dlE105 (CR1D)-, and dlE106 (CR3D)-infected cell
lysates. No coimmunoprecipitation was seen with cell lysates from dlE102 (CR2D) or pmE109, a mutant virus that produces
no detectable E1A protein due to an ATG to TTG point mutation in the initiator methionine. Introduction of mouse pRb into
SAOS-2 cells resulted in a flat and enlarged cell phenotype, whereas cotransfection of mouse pRb and MAV-1 E1A resulted
in a significant reduction of flat cells, presumably due to E1A binding pRb. CR1D and CR2D E1A proteins were less effective
at reducing the number of flat, enlarged cells induced by pRb expression than were the CR3D or wild-type E1A proteins.
The reduced ability of these mutants to inactivate pRb relative to wild-type E1A correlated with their reduced ability to bind
pRb in the in vitro coimmunoprecipitation experiments. As a measure of p107/MAV-1 E1A complex formation in MAV-1-
infected cells, we used mobility shift assays to examine cell extracts for the presence of p107-containing E2F protein–DNA
complexes. Mock-, dlE102-, and pmE109-infected cell extracts formed a p107-containing complex, whereas wild-type-
infected cell extracts did not. Thus the formation of a p107–E2F complex in wild-type- or these mutant-infected extracts
inversely correlated with the presence of E1A–p107 complexes identified in the in vitro coimmunoprecipitation experiments.
This is consistent with E1A–p107 complexes forming in wild-type MAV-1-infected cells. q 1996 Academic Press, Inc.
INTRODUCTION et al., 1984; Simon et al., 1987), and repress viral and
cellular transcriptional enhancers (Borelli et al., 1984;
Viral and host cell protein interactions play an im- Hen et al., 1985; Velcich and Ziff, 1985). E1A proteins
portant role in the pathogenesis of viral infections. Inter- also transform nonpermissive cells (Ruley, 1983) and in-
actions that occur during human adenovirus (hAd) infec- duce cell cycle progression by induction of cellular DNA
tions of cultured cells have been identified. Early region synthesis and mitosis in growth-arrested primary rodent
1A (E1A) proteins of hAds are multifunctional and associ- cells (Shimojo and Yamashita, 1968; Younghusband et
ate with a number of host proteins. Many of these cellular al., 1979; Braithwaite et al., 1983; Spindler et al., 1985).
proteins are involved in cell cycle regulation. It is hypoth- Mutational analysis of the hAd E1A gene has allowed
esized that host protein–E1A interactions are important correlation of many of the biological activities attributed
in altering the state of infected cells, causing them to to E1A with three specific regions of the protein that
enter the S phase of the cell cycle, thereby becoming are highly conserved among adenoviruses. The ability to
more permissive for viral DNA synthesis (Whyte et al., transactivate other genes resides within conserved re-
1988). E1A proteins function to regulate viral gene ex- gion 3 (CR3) of the 289-amino-acid (aa) E1A protein
pression (Berk et al., 1979; Jones and Shenk, 1979), acti- (Svensson and Akusja¨rvi, 1984). Conserved regions 1
vate transcription of both viral and cellular genes (Berk (CR1) and 2 (CR2) and the N-terminus are required for
et al., 1979; Jones and Shenk, 1979; Nevins, 1982; Gaynor transformation of rodent cells (Stein et al., 1990; reviewed
in Boulanger and Blair, 1991, and Shenk and Flint, 1991;
Corbeil and Branton, 1994). Induction of DNA synthesis1 Present address: Department of Molecular Microbiology and Immu-
is dependent on CR1 and CR2, whereas induction ofnology, St. Louis University School of Medicine, St. Louis, MO 63104.
mitosis and further cellular proliferation require only CR22 Present address: Marine Resources Research Institute, South Caro-
lina Department of Natural Resources, Charleston, SC 29422. (Zerler et al., 1987; Moran and Zerler, 1988; Howe et al.,
3 Present address: Plum Island Animal Disease Center, North Atlantic 1990; Stein et al., 1990; Howe and Bayley, 1992). Host
Area, Agricultural Research Service, United States Department of Agri-
proteins retinoblastoma protein (pRb), pRb-related pro-culture, Greenport, NY 11944.
tein (p107), p130, and cyclin A have been demonstrated4 To whom reprint requests should be addressed. Fax: (706) 542-
3910; E-mail: spindler@uga.cc.uga.edu. to associate with CR1 and CR2 of hAd E1A (Egan et al.,
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1988; Jelsma et al., 1989; Whyte et al., 1989; Giordano et MAV-1 sequence) and filled in using Klenow to produce
blunt ends. It was then digested with HindIII (5* of E1Aal., 1991; Li et al., 1993). Another cellular protein, p300,
also associates with E1A, requiring CR1 and the noncon- sequence), and the MAV-1 E1A-containing fragment was
inserted into HindIII– EcoRV-digested pcDNAI/Amp (In-served N-terminus of E1A for this association (Wang et
al., 1993). The E1A regions required for association with vitrogen) such that the E1A sequence was under the
control of the CMV promoter. This plasmid, pCME1A,these cellular proteins are also essential for the various
E1A functions displayed during an infection of cultured was then digested with HindIII and XbaI and ligated with
similarly digested pJ5V (Morgenstern and Land, 1990).cells. It is likely that E1A exerts its activity through these
cellular protein interactions. Hypotheses regarding the In the resulting plasmid, pE1AV, E1A is under the control
of the MMTV promoter. Mouse 3T6 cells plated in 35-functional importance of E1A–host cell protein interac-
tions during an infection have been proposed (Whyte et mm wells were cotransfected with 1 mg pE1AV and 0.1
mg pcDneo (Chen and Okayama, 1987) using Lipofectam-al., 1988), but have not been tested in the natural host.
The species specificity of adenoviruses limits the study ine (GIBCO BRL), following the manufacturer’s standard
protocol. Two days after transfection, 400 mg/ml G418of hAds to cell culture or nonpermissive animal hosts.
Study of mouse adenovirus type 1 (MAV-1) enables us to was added for selection. Two weeks after transfection,
isolated colonies were picked and expanded. Genomiccorrelate viral and host protein interactions with specific
aspects of pathogenesis in the natural host. DNAs were prepared from the cells (Laird et al., 1991)
and tested for the presence of E1A sequences by theInitial characterization of MAV-1 E1 revealed a single
major E1A transcript which overlaps the early region 1B polymerase chain reaction (PCR) using oligonucleotides
CR1 and MAVL883 as primers (Table 1). Positive cell(E1B) transcripts (Ball et al., 1989). Thus MAV-1 E1 differs
from hAd E1, which has two major E1A transcripts that lines were then tested by Western blot analysis for ex-
pression of E1A protein after induction with 1006–1007 Mdo not overlap E1B. We demonstrate here that the single
predicted MAV-1 E1A protein of 200 aa is made in in- dexamethasone. Six lines were isolated that expressed
E1A (data not shown), and the line designated 37.1 wasfected cells. The MAV-1 E1A protein has approximately
40% amino acid similarity to the 289-aa E1A protein from used in the studies presented here. 37.1 cells were main-
tained in DMEM containing 5% heat-inactivated calf se-hAd4, hAd5, and hAd7 within the three conserved regions
(Ball et al., 1988). Of the three conserved regions, MAV-1 rum and 200 mg/ml G418. For virus propagation, cells
were passaged one time in the absence of G418, andCR2 (aa 112–128) has the highest degree of similarity
to hAd CR2, with more than 50% of the residues being 1005 M dexamethasone was added 5–24 hr prior to infec-
tion. Dexamethasone was included in the agarose over-identical or similar (Ball et al., 1988). In particular it pos-
sesses the pRb binding motif (D)-L-X-C-X-E found in most lay of plaque assays.
hAd E1A proteins, the SV40 large T antigen, and E7 pro-
tein of human papilloma virus 16. Because this region MAV-1 mutant virus construction
has been shown to bind the cellular proteins pRb and
p107 (Egan et al., 1988; Whyte et al., 1989), we investi- Mutations were introduced into plasmids containing
genomic or cDNA sequences of MAV-1 by site-directedgated whether MAV-1 E1A associates with mouse cellu-
lar pRb and p107. We used biochemical and functional mutagenesis using oligonucleotides indicated in Table
1. Oligonucleotides were synthesized by Operon Tech-assays to demonstrate that these interactions occur dur-
ing a MAV-1 infection. nologies or the Molecular Genetics Instrumentation Fa-
cility, University of Georgia. Mutagenesis was carried out
on single-strand templates using the appropriate primerMATERIALS AND METHODS
and the Amersham oligonucleotide-directed in vitro mu-
Cells and viruses tagenesis system according to the manufacturer’s in-
structions. Templates and the resulting plasmids withMouse 3T6 fibroblast cells and mouse L929 cells were
E1A mutations are indicated in Table 2. Mutations weremaintained in Dulbecco’s modified Eagle’s medium
verified by restriction digest and/or DNA sequencing.(DMEM) supplemented with 5% heat-inactivated calf se-
pmE301 virus was isolated after cotransfection by therum. The human osteogenic sarcoma SAOS-2 cells ob-
calcium phosphate precipitation method (Gorman et al.,tained from the American Type Culture Collection were
1983) of mouse 3T6 cells with pMUT2 linearized withmaintained in DMEM supplemented with 15% heat-inac-
HindIII (Table 2) and MAV-1 DNA–protein complex (iso-tivated fetal bovine serum.
lated as in Dunsworth-Browne et al., 1980). A single mu-
tant virus plaque was identified by restriction digest ofMouse 37.1 cells
Hirt DNA (Hirt, 1967), plaque purified three times, and
used to produce a virus stock. pmE301 virus has a singlepZ112.F is a plasmid containing MAV-1 E1A cDNA se-
quence in the opposite orientation from pZ112 (Ball et point mutation in the first intron of early region 3 which
eliminates the EcoRI site while maintaining the aminoal., 1989). pZ112.F was linearized with BstBI (nt 2984 in
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TABLE 1
Oligonucleotides Used in This Work
Name Sequence Use
E3R1 5* TCTCGAGAGTTCCCCCCTAC 3* Eliminate EcoRI site at 79.4 m.u.
ATGoligo 5* CTTTTGACTCATTGTCGCG 3* Mutate E1A initiator ATG to TTG.
CR1 5* GTATGTCGTACGCCAGATTCTACTACTGCC 3* Delete E1A aa 35–78.
CR2 5* GTGGAGAGTTTTGAGATTGAGGTGTTCCCG 3* Delete E1A aa 111–129.
CR3g 5* ATTGAGGTGTTCCCGGGTCTGACTGGTAAG 3* Delete E1A aa 135–154 in genomic clones.
CR3c 5* ATTGAGGTGTTCCCGGGTCTGACTGATCTG 3* Delete E1A aa 135–154 in cDNA clones.
MAVL170 5* GGTTTTTTACTTTGCGGAGC 3* Left side PCR primer for E1A mutant screening.
MAVL255A 5* GGTGCGATTTTTCGACTTTTGACTCAA 3* Left side PCR primer for E1A mutant screening.
MAVL255T 5* GGTGCGATTTTTCGACTTTTGACTCAT 3* Left side PCR primer for E1A mutant screening.
MAVL883 5* GCAGACTCATCAGGAACTTC 3* Right side PCR primer for E1A mutant screening.
MAVL1134 5* GGTAACATATTGCAGCCTAC 3* Right side PCR primer for E1A mutant screening.
RoxL98 5* CATGCCGCCCAAAGCCCCGCGCAGAGCCGC 3* Linker for pCiteRb construction.
RoxL98c 5* GGCTCTGCGCGGGGCTTTGGGCGG 3* Linker for pCiteRb construction.
acid sequence of pVIII (Raviprakash et al., 1989; Beard mg plasmid DNA, the total DNA was adjusted to 20 mg
with herring sperm DNA, and the calcium phosphate pre-et al., 1990). pmE301 behaves like wild-type MAV-1 in all
characteristics assayed to date (Spindler, unpublished), cipitate was divided between two 60-mm plates of cells.
Twenty-four hours after transfection the plates were over-and is referred to as wild-type MAV-1 throughout this
work. laid with DMEM containing 2% heat-inactivated calf se-
rum, 1005 M dexamethasone, and 0.6% agarose.To construct viruses with mutations in E1A, we used
a method similar to one developed for making MAV-1 Plaques were analyzed for the presence of mutant
virus as follows. The plaques were picked into 0.5–1 mlE3 mutants (Beard and Spindler, 1996). pmE301 DNA–
protein complex was digested with EcoRI and partially of phosphate-buffered saline (PBS). An aliquot (0.125–
0.5 ml) of this was mixed with 0.1 volume of 4.5% NP-filled in using Klenow enzyme in the presence of dATP,
and the Klenow reaction was terminated by the addition 40/4.5% Tween 20. Proteinase K (250 mg/ml) was added,
and the samples were digested at 557 for 60 min. Sam-of EDTA to 25 mM. Plasmids containing mutated genomic
MAV-1 sequence (pTTG, pCR1g, pCR2g, or pCR3g, see ples were incubated at 957 for 10 min to inactivate the
proteinase K, ethanol precipitated, and resuspended inTable 2) were digested with HindIII and XbaI, releasing
the MAV-1 insert. The plasmid DNAs were then treated 10 ml water. One to five microliters was used as template
for PCR amplification. To identify deletion mutants, oligo-with EcoRI methylase to protect them from digestion with
EcoRI present in the pmE301 DNA–protein complex. The nucleotide primers flanking the mutation were used:
MAVL170 and MAVL1134 primers for the CR1 and CR3plasmid DNAs were ethanol precipitated, mixed with the
partially filled-in pmE301 DNA–protein complex, and co- deletions, and CR1 and MAVL883 primers for the CR2
deletion (Table 1). Plaques arising from the cotransfec-transfected into mouse 37.1 cells by the calcium phos-
phate precipitation method (Gorman et al., 1983). Five tion of pTTG were analyzed by differential PCR utilizing
MAVL255A or MAVL255T and MAVL883 primers (Tablemicrograms of DNA–protein complex was mixed with 4
TABLE 2
Templates and Resulting Mutagenized MAV-1 Plasmids and Viruses
Mutagenic
Templatea oligonucleotideb Mutagenized plasmid Mutant virus
pBHC2 E3R1 pMUT2 pmE301
pZ112 CR1 cDCR1 (E1A cDNA)
pZ112 CR2 cDCR2 ( 9 )
pZ112 CR3c cDCR3 ( 9 )
pMXD ATGoligo pTTG (E1A genomic DNA) pmE108, pmE109
pMXD CR1 pCR1g ( 9 ) dlE104, dlE105
pMXD CR2 pCR2g ( 9 ) dlE102, dlE103
pMXD CR3g pCR3g ( 9 ) dlE106, dlE107
a pBHC2, MAV-1 HindIII-C fragment cloned into pBS/ (Stratagene); pZ112 (Ball et al., 1989); pMXD (Ball et al., 1988).
b See Table 1.
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1). The PCR reactions for the differential screening con- pcDNAI/Amp at the EcoRV site. The wild-type MAV-1 E1A
expression construct, pCME1A, is described above.tained 0.5 mM Mg2/, and the annealing temperature of
527 was used to discriminate between priming of the pcDCR1, pcDCR2, and pcDCR3 are derivatives of pZ112
(Ball et al., 1989) in which nt 382–515, 610–668, andwild-type (MAVL255A) or mutant (MAVL255T) oligonucle-
otide from wild-type or mutant plasmid template controls. 682–742 of E1A are deleted, respectively. To construct
these plasmids, deletions were introduced into pZ112Plaques containing desired mutations were plaque-puri-
fied three times and virus stocks were prepared on 37.1 by site-directed mutagenesis as described above using
oligonucleotides CR1, CR2, and CR3c (Table 1), resultingcells. To verify the purity of the stocks and the presence
of the mutations, viral DNA samples were prepared for in pcDCR1, pcDCR2, and pcDCR3, respectively.
pCME1A, pcDCR1, pcDCR2, and pcDCR3 were di-PCR analysis from 100 ml of tissue culture supernatant
by boiling 5 min. The samples were then mixed briefly gested with BstBI, filled in using Klenow, and digested
with EcoRI. The cDNA-containing fragments werewith 10 ml StrataClean resin (Stratagene) and pelleted,
and the supernatant containing DNA was transferred to gel isolated and ligated to an EcoRV–EcoRI-digested
pcDNAI/Amp vector resulting in pCMV-CR1D, pCMV-a fresh tube. One microliter of the supernatant was used
in PCR fmol sequencing (Promega) and all mutant viruses CR2D, and pCMV-CR3D. The MAV-1 E1A initiator mutant
construct, pCMV-TTG, was made by digesting pTTG withhad the expected mutations. The viruses were named as
indicated in Table 2. BstBI, filling in using Klenow, then digesting with HindIII.
The 2984-bp BstBI–HindIII fragment of pTTG was gel
Plasmids used for in vitro production of mouse isolated and ligated to a HindIII– EcoRV-digested
cellular proteins pcDNAI/Amp, resulting in pCMV-TTG.
pCiteRb contains the full length mouse pRb cDNA Antisera
downstream of a cap-independent translation enhancer
sequence to increase the in vitro translation efficiency The monoclonal antiserum, XZ104, raised against a
human pRb polypeptide corresponding to amino acidsin rabbit reticulocyte lysates. To construct pCiteRb, a
fragment containing the mouse pRb cDNA was gel iso- 387–928, was provided by E. Harlow (Hu et al., 1991).
The mouse pRb polyclonal antiserum was made againstlated from SacII–XmnI-digested pBSK/115Rox, which is
a derivative of pJ3-115 (Bernards et al., 1989), provided a GST–mouse pRb fusion protein expressed from pGEX-
1NMuRB, a plasmid containing the N-terminal 386 aa ofby J. Horowitz. The isolated fragment was digested with
BamHI and the resulting BamHI–SacII fragment was gel mouse pRb. Antisera and plasmid were both provided by
J. Horowitz (Sterner et al., 1995). We produced additionalpurified, mixed with the RoxL98 and RoxL98c linkers (Ta-
ble 1), and ligated to BamHI–NcoI-digested pCite-2b (No- antiserum by inducing fusion protein expression in Esch-
erichia coli, collecting the fusion protein on glutathionevagen), resulting in pCiteRb. Mouse p107 cDNA under
the control of the T7 promoter in pmp107 was used for agarose beads, and using it to immunize rabbits (Univer-
sity of Georgia Animal Resources). SD9 is a monoclonalin vitro transcription and translation and was provided
by E. Harlow (Zhu et al., 1993). antiserum raised against human p107 which cross-re-
acts with mouse p107 and it was kindly provided by E.The mouse pRb expression plasmid used in the SAOS-
2 transfection experiments, pmRb-SVE, was constructed Harlow (Dyson et al., 1993).
A polyclonal antiserum to MAV-1 E1A was producedas follows from a mouse pRb cDNA containing plasmid,
pT7115.Rox, a derivative of pJ3-115 obtained from R. Ber- as follows. The MAV-1 E1A cDNA sequence from nt 360
to 3260 of Z112 (Ball et al., 1989) was inserted as anards (Bernards et al., 1989). pSVE was obtained by re-
moving hAd E1A sequences from 13S-SVE (provided by BamHI–HindIII fragment into BamHI–HindIII-digested
pATH2 (Koerner et al., 1991), producing an E. coli trpE–P. Hinds). pSVE [a variant of pJ3V (Morgenstern and
Land, 1990)], whose backbone is the large PvuII fragment MAV-1 E1A fusion protein expression plasmid, pTE1A29.
The fusion protein expressed by pTE1A29, consisting ofof pBluescript (SK/), was linearized with KpnI, and the
ends were blunted using T4 DNA polymerase. This was MAV-1 E1A aa 27–200, was overproduced in E. coli,
isolated from polyacrylamide gels, and used to immunizeligated to the PvuII fragment of pT7115.Rox containing
the mouse pRb cDNA, resulting in pRox-SVE. The large rabbits (Bethyl Laboratories, Inc.). Antisera from two rab-
bits, AKO7 and AKO8, was purified where indicated byEcoRI– PstI fragment of pRox-SVE was isolated and li-
gated to the EcoRI– PstI fragment of pT7115.Rox, re- DEAE Affi-Gel Blue (Bio-Rad) affinity chromatography ac-
cording to the manufacturer’s instructions.sulting in pmRb-SVE which contains the entire mouse
pRb cDNA downstream of the SV40 promoter.
In vitro-translated protein mixing
Construction of MAV-1 E1A expression plasmids
In vitro-translated [35S]methionine-labeled protein was
produced in rabbit reticulocyte lysate (Promega) from inFor the SAOS-2 transfection experiments, MAV-1 E1A
wild-type and mutant cDNAs were subcloned into vitro-transcribed RNA. The truncated E1A product used in
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Fig. 1 was transcribed from pZ150.6 (a carboxy-terminal In vitro-translated protein/infected cell lysate mixing
deletion clone of pZ150 consisting of the first 514 nucleo-
Mouse 3T6 cells were infected as described for West-tides of the E1A cDNA sequence) and digested with BglI,
ern analysis. At 19 and 38 hr p.i., 9 1 106 cells wereresulting in only the first 120 amino acids of E1A being
harvested and lysed in 40 ml of E1A lysis buffer. Tentranslated. pZ150.6 was linearized and used for in vitro
microliters of infected cell lysate, 20 ml in vitro-translatedtranscription with T7 RNA polymerase (Promega). The
mouse pRb or mouse p107 labeled with [35S]Trans labelcRNA was then added to rabbit reticulocyte lysate for in
(ICN), and 220 ml E1A lysis buffer were mixed by rotationvitro translation.
at 47 for 1 hr. In vitro-translated mouse pRb and mouse
p107 for these experiments were obtained from coupled
Western blot analyses transcription/translation of pCiteRb and pmp107, respec-
tively, using the TNT kit from Promega with [35S]Trans
Mouse 3T6 cells were infected with wild-type or mu- label. Proteins were precipitated with the appropriate
tant virus at a multiplicity of 5 PFU/cell. At the indicated antisera (1 ml of purified normal rabbit serum, 1 ml of
times postinfection (p.i.) 2.5 1 106 cells were harvested purified MAV-1 E1A polyclonal antiserum, 25 ml of p107
and lysed in 40 ml of cracking buffer (0.01 M NaPO4 , pH monoclonal antiserum, or 1 ml of purified mouse pRb
7.2, 1% b-mercaptoethanol, 1% SDS, 6 M urea) at 377 for polyclonal antiserum) by rotating at 47 for 30 min. Com-
30–180 min. An equal volume of 21 Laemmli gel sample plexes were collected by addition of 100 ml protein A –
buffer (LGSB, 0.125 M Tris, pH 6.8, 4% SDS, 20% glycerol, Sepharose (Pharmacia Biotech; 10% v/v in E1A lysis
10% b-mercaptoethanol, and 0.002% bromophenol blue) buffer) and continued rotation for 30 min at 47. Immune
was added to the cell extract and boiled 15 min. Twenty complexes were purified by washing the Sepharose
microliters was electrophoresed on a denaturing 10% three times with 1 ml E1A lysis buffer and once with 1
polyacrylamide gel. MAV-1 E1A protein was detected by ml 50 mM Tris, pH 6.8. Forty microliters of 21 LGSB was
Western analysis using the Amersham ECL Western de- added to the Sepharose and boiled for 5 min, and pro-
tection kit with a 1:2000 dilution of the MAV-1 E1A poly- teins were resolved on SDS–polyacrylamide gels. La-
clonal antiserum, AKO7-147, described above. beled proteins were detected using a phosphorimager
(Molecular Dynamics) and quantitated using ImageQuant
software (Molecular Dynamics).Immunoprecipitation of E1A from infected cells
SAOS-2 transfection experimentsMouse L929 cells grown on 60-mm plates (2 1 106
cells/plate) were infected with wild-type MAV-1 at a multi-
SAOS-2 cells (7 1 105) on 60-mm plates were trans-
plicity of 5 PFU/cell for 48 hr. Cytosine arabinoside (20
fected as described (Hinds et al., 1992). Transfections
mg/ml) was added to the media 9 hr p.i. and was replen-
included 3.9 mg of the mouse pRb expression plasmid
ished every 8–12 hr. Prior to labeling, cells were washed
mRb-SVE, plus 3.9 mg MAV-1 E1A or MAV-1 E1A mutant
three times with 0.15 M NaCl or 11 PBS and resus-
plasmid (pCME1A, pCMV-CR1D, pCMV-CR2D, pCMV-
pended in media lacking phosphate or methionine and
CR3D, or pCMV-TTG) or vector control (pSVE), and 0.4
supplemented with 2% dialyzed newborn calf serum.
mg of pBSpacDp [provided by R. Ivarie, U. of Georgia (de
After 3 hr, 1 mCi 32PO4 or 200 mCi [
35S]methionine was
la Luna et al., 1988)], a plasmid encoding puromycin
added to the cells in 2 ml of media. Cells were main-
resistance. All transfections included 0.25 mg/ml puromy-
tained in label for 3 hr, washed once with 11 PBS, then
cin and were supplemented with herring sperm DNA to
lysed in 1 ml of E1A lysis buffer (250 mM NaCl, 50 mM
obtain a total of 12 mg DNA/60-mm plate. Flat cell assays
Tris, pH 7.4, 0.1% Nonidet-P40, supplemented with 0.1
and quantitation were done as described (Hinds et al.,
mg/ml aprotinin) for 30 min on ice. Lysates were pre- 1992).
cleared with 20 ml of preimmune serum and 200 ml of
fixed Staphylococcus aureus for 2 hr. Two microliters of
Mobility shift assays
preimmune (AKO7-0) or a-E1A antiserum (AKO7-147)
was added to 14 of the precleared supernatant from one E2F electrophoretic mobility shift assays were per-
plate and rotated for 1 hr at 47, followed by the addition formed using nuclear extracts prepared by the modified
of 200 ml of fixed S. aureus and further rotation for 30 method of Dignam et al. (1983; Abmayr and Workman,
min at 47. Immune complexes were purified by washing 1994). A double-stranded E2F oligonucleotide (66-mer)
the S. aureus three times with 1 ml E1A lysis buffer then corresponding to the double site probe of Obert et al.
once with 1 ml 50 mM Tris, pH 6.8. Forty microliters of 21 (1994) was used, except that it had additional sequence
LGSB was added to the purified complexes and boiled for at the 3* end (GGGATCCACTAGTT), corresponding to the
5 min, and proteins were resolved on SDS–polyacryl- multiple cloning site region of the double site probe when
amide gels (Laemmli, 1970). Labeled proteins were visu- it is prepared by EcoRI–XbaI digestion from pKS-E2a
(kindly provided by P. Hearing, State University of Newalized by fluorography and autoradiography.
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type-infected mouse L929 cells were treated with cyto-
sine arabinoside, an inhibitor of DNA replication, to accu-
mulate early proteins (Gaynor et al., 1982). The cells were
labeled with 32PO4 or [
35S]methionine. Lysates were pre-
pared and precipitated with preimmune (Fig. 1, lanes 7,
9, and 11) or a-E1A antiserum (Fig. 1, lanes 8, 10, and
12). A viral-specific band migrating slightly slower than
30 kDa was precipitated from infected cells with the a-
E1A antiserum. The 30-kDa size was higher than the
predicted molecular weight of 22 kDa for MAV-1 E1A.
hAd E1A proteins also migrate more slowly than their
predicted molecular weight in SDS–polyacrylamide gels
(Yee et al., 1983; Harlow et al., 1985). hAd E1A proteins
are phosphorylated although the significance is unknown
(Gaynor et al., 1982; Yee et al., 1983; Yee and Branton,
1985a). In the hAds, mutations of phosphorylation sites
have not altered the abilities of the E1A proteins to func-
tion in the in vitro or infected cell culture systems tested
FIG. 1. Immunoprecipitation of E1A proteins. (A) E1A mRNAs were (Richter et al., 1988; Dumont et al., 1989). Evidence for
transcribed using T7 RNA polymerase and translated in a rabbit reticu- phosphorylation of MAV-1 E1A is seen in the immunopre-
locyte lysate. The [35S]Met-labeled translation products from a full
cipitation of 32P-labeled E1A (Fig. 1, lane 10).length construct (aa 1–200) and a truncation (aa 1–120) are shown
(lanes 1 and 2). The translation products were precipitated with preim-
In vitro mixing experiments demonstrate anmune (P, lanes 3 and 5) or a-E1A-immune (I, lanes 4 and 6) sera and
analyzed on a 12% SDS–polyacrylamide gel. (B) MAV-1-infected cells association between E1A and pRb
were labeled with 32PO4 (lanes 7–10) or [35S]Met (lanes 11 and 12). that is dependent on CR2
Cells were mock infected (lanes 7 and 8) or infected for 48 hr in the
presence of 20 mg/ml cytosine arabinoside (araC). Antisera were as in The presence of the pRb binding motif, D-L-X-C-X-E,
A; samples were electrophoresed on a 10% polyacrylamide gel. E1A in CR2 of MAV-1 E1A prompted an investigation of a
and positions of molecular weight standards are indicated.
potential interaction between MAV-1 E1A and mouse cel-
lular pRb. Using either a-E1A or a-pRb antiserum, coim-
York, Stony Brook). The probe was labeled with [a-32P]- munoprecipitation of MAV-1 E1A and mouse pRb was
dATP and Klenow polymerase and purified on a 7% acryl- observed using in vitro-transcribed and -translated prod-
amide gel. DNA binding assays (13 ml) contained 2 mg ucts made from cloned cDNAs of MAV-1 E1A and mouse
of sonicated salmon sperm DNA, 10 mg of nuclear ex- pRb (data not shown). To determine whether specific
tract, and 1 ml of monoclonal antibody (where indicated) regions of MAV-1 E1A are required for the in vitro interac-
in 20 mM HEPES (N-[2-hydroxyethyl]piperazine-N*-[2- tion of MAV-1 E1A and mouse pRb, we used MAV-1
ethanesulfonic acid]), pH 7.5, 100 mM KCl, 10% glycerol, E1A cDNAs with deletions in one of the three conserved
5 mM MgCl2 , 0.2 mM EDTA, 0.5 mM dithiothreitol, 0.5 mM regions or cDNAs that encoded E1A proteins truncated
phenylmethylsulfonyl fluoride, 0.1% Nonidet-P40. After a at the carboxy or amino terminus to produce mutant E1A
10-min preincubation at room temperature, 1 ml of probe proteins (Fig. 2). Coimmunoprecipitation of mouse pRb
(50,000 cpm; 17–20 ng) was added and the reactions was observed with the CR1 and CR3 deletion mutants
were incubated for 45 min at room temperature. The as well as with the N-termD1 and C-termD2 mutants
reactions were electrophoresed on 4% acrylamide gels (data not shown). No coimmunoprecipitation of mouse
at 47. The control mouse monoclonal antibody, 13D210, pRb was observed with the CR2 deletion mutant and
was obtained from B. Stillman (Cold Spring Harbor, NY), very little was seen with the N-termD2 mutant (data not
and was prepared against hAd5 E1B 55K protein. shown).
RESULTS Association of pRb and p107 with MAV-1 E1A in
infected cell lysatesThe predicted MAV-1 E1A protein is made in infected
mouse cells To examine the sequence requirements for the pRb-
E1A association during an infection we used MAV-1 viralA polyclonal antiserum was produced against aa 27 –
200 of MAV-1 E1A and was tested for specificity against mutants. The E1A CR1, CR2, and CR3 deletions used for
the in vitro experiments were transferred into the MAV-1in vitro-transcribed and -translated E1A proteins. Both a
full length and a truncated E1A translation product were genome to produce viral mutants. Mouse 3T6 fibroblasts
were infected with each of the mutants and the steady-precipitated with this antiserum but not with the preim-
mune serum (Fig. 1, lanes 1–6). Mock-infected or wild- state E1A protein expression levels were examined by
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grated faster than wild-type E1A as expected for proteins
with deletions of 19 and 20 aa, respectively (Fig. 3, lanes
3, 4, 7, and 8). Despite a 43-amino-acid deletion, con-
firmed by DNA sequencing, the CR1D mutant protein
expressed from dlE105 migrated more slowly than the
wild-type E1A protein (Fig. 3, lanes 5 and 6). Similar
anomalous migration was observed from the in vitro-
translated CR1 deletion cDNA (data not shown). The rea-
son for this is unknown, but a hAd5 E1A protein mutant
with a deletion in CR1 (aa 70–81) also migrates anoma-
lously (Egan et al., 1988).
We were unable to detect pRb from mouse cells in
culture. Therefore we examined whether the same re-
gions that are required for an association between in
vitro-translated E1A and pRb products were required for
the association of proteins from infected cells. MouseFIG. 2. Schematic diagram of the MAV-1 E1A protein and deletion
3T6 fibroblasts were infected with wild-type MAV-1 ormutants. The three conserved regions of the protein are contained
within the first exon and are depicted as open, numbered boxes with one of the deletion mutant viruses. Extracts from the
the amino acid numbers indicated above at the boundaries of each infected cells were prepared and mixed with radioac-
region. Splice junctions are identified by the arrows below the diagram tively labeled in vitro-translated pRb followed by immuno-at aa 157 and 198. The amino acids flanking the deletion junctions in
precipitation with a-E1A antiserum (Fig. 4). Exogenouslythe mutant E1A proteins are indicated (CR1D, CR2D, CR3D, C-termD2,
N-termD1, N-termD2). The TTG mutant (*) consists of a single nucleo- added pRb was coimmunoprecipitated from wild-type in-
tide change from an ATG to TTG at the initiator methionine. fected cells at both early and late times p.i. (Fig. 4, lanes 5
and 8). Both dlE105 (CR1D)- and dlE106 (CR3D)-infected
cells showed coimmunoprecipitation of pRb and E1A,Western analysis (Fig. 3). E1A expression was detectable
although to lower levels, 4% and 55% of wild-type, respec-from infected cells at levels comparable to wild type from
tively (Fig. 4, lanes 10, 12, 18, 20). The low proportioneach of the mutants except the TTG translational initiator
of pRb coimmunoprecipitated from dlE105-infected cellsmutant, pmE109, from which no E1A expression was de-
compared to wild-type-infected cells may reflect a coop-tectable. Wild-type E1A protein migrated slightly slower
erative role for E1A CR1 in pRb association with E1A.than the 30-kDa marker (Fig. 3, lanes 11 and 12). E1A
expressed from dlE102 (CR2D) and dlE106 (CR3D) mi- pRb coimmunoprecipitation did not occur with mock-,
FIG. 3. E1A protein expression from infected mouse 3T6 fibroblasts. Mouse 3T6 cells were infected with wild-type (wt) or mutant MAV-1 at a
multiplicity of 5 PFU/cell. Cells were mock infected (lanes 1, 2) or infected for 22 and 40 hr with wt MAV-1 (lanes 11, 12) or one of the following
deletion mutants: dlE102 (CR2D, lanes 3 and 4), dlE105 (CR1D, lanes 5 and 6), dlE106 (CR3D, lanes 7 and 8), pmE109 (TTG, lanes 9 and 10). E1A
proteins were electrophoresed on a 10% SDS–polyacrylamide gel, blotted to a membrane, and detected by Western analysis with purified a-E1A
antiserum, AKO7-147. Wild-type MAV-1 E1A protein, indicated by the arrow on the right, migrates slightly slower than the 30-kDa molecular weight
marker.
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FIG. 4. Coimmunoprecipitation of in vitro-translated mouse pRb from infected mouse cell lysates. Mouse 3T6 cells were mock infected (lanes 1–
3) or infected with wild-type (wt) or mutant MAV-1, harvested at 19 and 38 hr p.i. (hpi), and lysed in E1A lysis buffer. Equal portions of infected cell
lysates were mixed with [35S]Trans-labeled, in vitro-translated mouse pRb, and immunoprecipitation was performed with normal rabbit serum (NRS),
a-E1A antiserum, or a-mouse pRb antiserum. Immunoprecipitated complexes were resolved on two 12% polyacrylamide gels (lanes 1–17 and 18–
25). Positions of full length in vitro mouse pRb translation product and the molecular weight markers are indicated. The full length pRb in vitro
translation product coimmunoprecipitated by the a-E1A antiserum was quantitated by phosphorimetry. Percentages referred to in the text represent
the mean value from four independent experiments, where the quantity of pRb coimmunoprecipitated with the E1A protein from cells infected for
38 hr with wt MAV-1, using a-E1A antiserum, was defined as 100%. Amounts of pRb coimmunoprecipitated with the E1A protein from MAV-1 E1A
mutant-infected cell lysates are given as the percentage of wt E1A coimmunoprecipitation. CR1D, dlE105; CR2D, dlE102; CR3D, dlE106; TTG,
pmE109.
dlE102 (CR2D)-, or pmE109 (TTG)-infected cells at either expressed from a plasmid in SAOS-2 cells, which lack a
full length functional pRb. When human pRb is introducedtime p.i. (Fig. 4, lanes 2, 14, 16, 22, 24). The results from
these experiments are consistent with those of in vitro into SAOS-2 cells and expressed, the cells cease to di-
vide and become greatly enlarged due to the ability ofmixing experiments (data not shown).
p107, a cellular protein related to pRb, associates with pRb to block progression from the G0/G1 phase of the
cell cycle (Huang et al., 1988; Goodrich et al., 1991; Mitt-hAd E1A (Yee and Branton, 1985b; Harlow et al., 1986).
The N-terminal portion of CR2 of hAd E1A is required for nacht et al., 1991; Templeton et al., 1991; Hinds et al.,
1992). However, coexpression of hAd E1A with pRb inbinding pRb and p107 (Whyte et al., 1989; Dyson et al.,
1992b). Exogenously added in vitro-translated mouse SAOS-2 cells reduces or abolishes the arrested growth
phenotype (Hinds et al., 1992). This reversal of growthp107 was coimmunoprecipitated with E1A protein from
wild-type virus-infected cells using a-E1A antiserum (Fig. arrest has been proposed to be due to the ability of hAd
E1A to effectively inactivate pRb by associating with it.5, lanes 5 and 8). The ability of MAV-1 E1A mutant pro-
teins to associate with p107 paralleled their ability to Similarly, when pRb and antisera specific for pRb were
cointroduced into SAOS-2 cells, the arrested growth phe-bind pRb. A reduced amount of p107 was coimmunopre-
cipitated with E1A from both dlE105 (CR1D)- and dlE106 notype was reduced or abrogated (Goodrich et al., 1991).
SAOS-2 cells cotransfected with mouse pRb, a control(CR3D)-infected cells (6 and 83% of wild-type, respec-
tively, the mean of three experiments) compared to wild- vector plasmid, and a puromycin-resistance plasmid re-
sulted in the characteristic flat, greatly enlarged cell phe-type infected cells (Fig. 5, lanes 10, 12 and 18, 20). Mouse
p107 was not coimmunoprecipitated from mock-, dlE102 notype after 3 days of selection in puromycin that per-
sisted until at least 12 days after selection, when the(CR2D)-, or pmE109 (TTG)-infected cells (Fig. 5, lanes 2,
14, 16, 22, and 24). cells were counted (data not shown). Cotransfection with
mouse pRb and wild-type MAV-1 E1A plasmids resulted
in a significantly reduced number of enlarged cells. OnlyMAV-1 E1A and pRb effects on SAOS-2 cells
4% of the control number of enlarged cells (resulting from
The in vitro coimmunoprecipitation experiments estab- cotransfection of pRb and vector control) was observed
lished the existence of a biochemical interaction be- when E1A was cotransfected with mouse pRb (Fig. 6).
tween MAV-1 E1A and mouse pRb. To demonstrate the This suggests that mouse pRb is inactivated in the pres-
functional importance of this interaction, we assayed the ence of wild-type MAV-1 E1A. To determine which re-
gions of E1A are required for this inactivation of theability of MAV-1 E1A to inactivate the function of pRb
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FIG. 5. Coimmunoprecipitation of in vitro-translated mouse p107 from infected mouse cell lysates. Infected cell extracts were prepared as in Fig.
4 and equal portions were mixed with [35S]Trans-labeled, in vitro-translated mouse p107. Immunoprecipitation was performed with normal rabbit
serum (NRS), a-E1A antiserum, or a-p107 antiserum. Immunoprecipitated complexes were resolved on two 12% polyacrylamide gels (lanes 1–17
and 18–25). Positions of full length in vitro mouse p107 translation product and the molecular weight markers are indicated. The full length mouse
p107 in vitro translation product coimmunoprecipitated with wild-type or mutant E1A proteins by the a-E1A antiserum was quantitated as in Fig. 4.
Percentages referred to in the text represent the quantitation from three independent experiments. Virus designations are as in Fig. 4.
mouse pRb, various E1A deletion mutant expression not shown), nor were they toxic to the cells, because
patches of dividing cells were observed in transfectionsplasmids were cotransfected into SAOS-2 cells with the
mouse pRb plasmid. Flat, enlarged, nondividing cells with each construct. Unlike cotransfection of the wild-
type E1A plasmid, cotransfection of the initiator mutantwere counted for each mutant and compared to the num-
ber of enlarged cells produced from pRb alone (Fig. 6). E1A plasmid (pCMV-TTG) and pRb did not result in a
reduced number of flat cells relative to cotransfection ofNone of the E1A constructs induced the flat cell morphol-
ogy when transfected in the absence of mouse pRb (data the vector control plasmid and pRb. In fact, the number
of flat cells produced by cotransfection of pCMV-TTG
was almost double the number resulting from cotransfec-
tion of pRb and the control vector. Transfection of SAOS-
2 cells with pCMV-TTG in the absence of pRb did not
result in flat cells (data not shown) so the increase in
the number of flat, enlarged cells in the cotransfection
with pRb is not due to a direct activity of the mutant E1A.
When the various E1A deletion mutant plasmids were
cotransfected with pRb, fewer flat cells resulted than with
pRb and vector control, but the reductions were not as
large as those seen with wild-type E1A. The coexpres-
sion of CR3D E1A with pRb reduced the number of flat
cells to 11% of the control, whereas the expression of
the CR1D and CR2D mutant E1As resulted in more flat,
enlarged cells (34 and 17%, respectively). This indicates
that the CR1D and CR2D E1A proteins were less effec-
tive at reversing the effect of mouse pRb in this assay
than CR3D or wild-type E1A.FIG. 6. Quantitation of flat, enlarged cell production by cotransfection
of SAOS-2 cells with mouse pRb and MAV-1 E1A. SAOS-2 cells were
cotransfected with three plasmids: (1) the mouse pRb expression plas- p107–E2F complexes in MAV-1-infected cells
mid, mRb-SVE; (2) either a control vector, pSVE, or a MAV-1 E1A expres-
sion plasmid; and (3) a puromycin-resistance plasmid, pBSpacDp. After p107 is present at low or undetectable levels in the
12 days of selection in puromycin, the flat, enlarged cells were counted. mouse cells we have used for MAV-1 infection, including
The fraction of total cells transfected with pRb and the control vector the L929, 3T6, and SP2/0 cell lines, and primary embryo
that were enlarged was set at 100% for each experiment. The numbers
fibroblasts (Smith and Spindler, unpublished). Thereforeof flat, enlarged cells counted for each sample are reported as a per-
we have not been able to detect a p107–MAV-1 E1Acentage relative to pRb and the control vector. Quantitation represents
the mean from three independent experiments. complex by coimmunoprecipitation of cellular p107 and
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experiments (lanes 8–10, 16–18, and data not shown).
In contrast to the results with wt virus, extracts from cells
infected with the CR2D or the TTG mutant had little or
none of the infected-cell specific complex A, but had
complexes similar to the mock complex (bands B and C,
lanes 11, 12, 19, and 20). The amount of B/C complexes
seen in the CR2D and TTG mutant extracts decreased
in the presence of a-p107 monoclonal antibodies, with
the accompanying appearance of new complexes D or
E (lanes 13 and 21). We conclude that E2F complexes
that contained p107 formed in the mutant-infected ex-
tracts. We suggest that the appearance of these p107-
containing complexes was due to the absence of MAV-1
E1A capable of binding p107.
FIG. 7. E2F mobility shift assays. An E2F double-site probe was
labeled with 32P and incubated with no cell extract (lanes 1, 14, 15) or DISCUSSION
mock- or MAV-1 wild-type- or mutant-virus-infected 3T6 cell extracts
as indicated (lanes 2–13 and 16–21), and complexes were resolved Human adenovirus studies have identified interactions
on two 4% polyacrylamide gels (lanes 1–13 and 14–21). Reactions that occur between E1A and host cell proteins, most of
contained no antibodies (‘‘none’’) or control (13D210) or a-p107 (SD-9)
which are involved in cell cycle regulation. Specific re-antibodies as indicated above the lanes. The letters A–E on the left
gions of E1A required for these interactions have beenrefer to complexes discussed in the text. Ab, antibody.
defined through extensive mutational analysis. pRb,
p107, and p130 require CR2 for efficient association with
E1A (Egan et al., 1988; Jelsma et al., 1989; Whyte et al.,E1A in infected cells. Mouse p107 associates with the
transcription factor E2F and the formation of this complex 1989; Giordano et al., 1991; Dyson et al., 1992a; Barbeau
et al., 1993, 1994; Li et al., 1993; Mayo et al., 1993).can be measured in mobility shift assays using an E2F-
specific DNA probe (Corbeil et al., 1995). Using a mobility Deletion of CR1 significantly reduces associations with
pRb and p130 but only slightly reduces the amount ofshift assay, we examined whether we could detect an
E2F–DNA binding complex in mock-infected cells that p107 bound by E1A (Egan et al., 1988; Barbeau et al.,
1993, 1994). CR1 and CR2 appear to play a significantcontained mouse p107 and that would be absent or re-
duced in amount in wild-type MAV-1-infected cells (Fig. role in both cellular protein binding and a number of E1A-
associated functions, suggesting a possible correlation7). A 32P-labeled DNA oligonucleotide containing two E2F
sites was used in these experiments (Obert et al., 1994). between the two.
pRb, p107, and p130 are involved in the regulation ofCell extracts were prepared from mock-infected 3T6 cells
or from 3T6 cells infected for 20 hr. The probe showed cell proliferation of quiescent cells. pRb (p105) is the
product of the retinoblastoma susceptibility gene andno specific high-molecular-weight complexes in the ab-
sence of cell extract, and was not affected by the pres- is a tumor suppressor protein. Hypophosphorylated pRb
forms a complex with and inhibits the activity of certainence of control or a-p107 monoclonal antibodies (Fig.
7, lanes 1, 14, 15). Mock-infected extracts produced a E2F (E2F-1,2,3) transcription factors during the G1 phase
of the cell cycle. p107 and p130, pRb-related phosphopro-complex (band B, Fig. 7, lane 2) which shifted in the
presence of a-p107 monoclonal antibodies (bands C, D, teins, also form complexes with specific E2F transcrip-
tion factors and cyclin A (p60cycA) and E in a cell cycle-and E, lane 4) but not with control antibodies (lane 3). A
faster migrating complex was seen in wt-virus-infected dependent manner during the G1 and S phases or during
the G0 and G1 phases, respectively (Cao et al., 1992;extracts (band A, lane 5). Because this complex was
unaffected by the presence of a-p107 monoclonal anti- Devoto et al., 1992; Lees et al., 1992; Shirodkar et al.,
1992; Cobrinik et al., 1993). These phosphoprotein/E2Fbodies (lane 7), we conclude that it does not contain
p107. This complex was also seen, and also not shifted complexes are disrupted when hAd E1A binds to either
pRb or p107 (Bagchi et al., 1990; Bandara and Laby the presence of a-p107 monoclonal antibodies, in
CR1D and CR3Dmutant-infected extracts (band A, lanes Thangue, 1991; Chellappan et al., 1991; Mudryj et al.,
1991), enabling the E2F transcription factors to activate8–10 and 16–18). The slightly faster mobility of the A
complex in wt-infected cells compared to dlE105 and promoters of both viral and cellular genes containing E2F
sites, including many S-phase-specific genes. Some hAddlE106 was not reproduced in three other experiments
(data not shown). For the CR1D and CR3D mutant ex- E1A CR2 deletion or point mutants that fail to bind pRb
efficiently yet maintain association with p107 show re-tracts, the presence of B/C complexes (similar to those
seen in mock) and appearance of additional complexes duced levels of in vitro E2F activity, presumably due to
a lack of free and active E2F (Corbeil and Branton, 1994).(D, E) upon addition of a-p107 antibody varied in multiple
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There are other CR2 point mutants that are unable to or 0% of wild-type, respectively). Similar results were ob-
tained for mouse p107 in dlE105- and dlE102-infectedbind pRb yet bind p107 or p130 and activate E2F, sug-
gesting that E2F activation may also result from its re- cells. Thus both CR1 and CR2 are needed for efficient
binding of pRb and p107 by MAV-1 E1A during an infec-lease from p107 or p130 (Corbeil and Branton, 1994).
Release of E2F from complexes with these cellular pro- tion in cell culture. These results are consistent with hAd
studies.teins triggers entry of the cell into S phase, allowing both
cellular and viral DNA synthesis to occur. Thus adenovi- The biochemical interactions reported here were cor-
roborated by functional assays for the interaction be-ruses manipulate the cells they infect through viral and
host protein interactions to create a favorable environ- tween MAV-1 E1A and mouse pRb or p107. SAOS-2 cells,
which lack a functional pRb, were used to assay thement for their replication.
In these studies MAV-1 E1A associated with at least effects of MAV-1 E1A on mouse pRb. Introduction of
mouse pRb into SAOS-2 cells induced the same pheno-two of the cellular proteins found to associate with hAd
E1A. Experiments with in vitro-translated E1A and mouse type of arrested growth as does introduction of human
pRb. This was expected since mouse pRb and humanproteins demonstrated an E1A association with both
mouse pRb and p107 (data not shown). Results from the pRb protein sequences are 91% identical (Bernards et
al., 1989). Our experiments demonstrated that MAV-1 E1Ain vitro mixing experiments with mouse pRb and mutant
E1As showed essentially no E1A–pRb association with reversed the effect of mouse pRb (similar to the effect of
hAd E1A on human pRb) when cointroduced into SAOS-either a CR2 deletion or an N-terminal truncation of the
first 100 amino acids (thereby lacking CR1) (data not 2 cells. This E1A effect was dependent on the presence
of CR1 and CR2, the two regions found to be most im-shown). However, the CR1 deletion and the CR3 deletion
mutant had detectable levels of pRb association. There- portant for interacting with mouse pRb in infected cells.
The CR3D E1A had only a slightly reduced ability to alterfore CR2 and a portion of the N-terminus of E1A appear
to be required for association to occur between the two the phenotype induced by pRb in SAOS-2 cells compared
to wild-type E1A. This correlates with its slightly reducedin vitro-translated proteins.
Attempts to detect the E1A–pRb interactions directly ability to bind pRb compared to wild-type E1A (Fig. 4).
The reasons for the increased number of flat cells seenin infected cells by coimmunoprecipitation were unsuc-
cessful (Smith and Spindler, unpublished), possibly for with the TTG mutant E1A are not known. Even if some
E1A was translated from the TTG, it would not explainthe following reasons. pRb was not produced at detect-
able levels in the mouse L929 and 3T6 cells that we the increase in the number of flat cells produced, since
the coexpression of wild-type E1A with pRb significantlyused for infection by MAV-1, as measured by immunopre-
cipitation of labeled infected cells or by Western blot reduced the number of flat cells. In summary, the SAOS-
2 cell experiments demonstrated that MAV-1 E1A proteinanalysis (Smith and Spindler, unpublished). One cell line,
SP2/O (mouse splenocytes), produced detectable levels expression in SAOS-2 cells altered the pRb-induced phe-
notype, suggesting that the interaction between E1A andof both mouse pRb and mouse p107, but it was not pro-
ductively infected by MAV-1. In addition, a protein of ap- pRb inactivated the pRb. Inactivation of pRb is hypothe-
sized to deregulate the cell cycle of the infected cell,proximately 100 kDa is produced in infected cells which
we were unable to preclear from extracts using a variety creating a more permissive environment for viral replica-
tion (Whyte et al., 1988).of sera. Thus the presence of this protein in all immuno-
precipitations from infected cells obscured any pRb that The biochemical interaction between E1A and p107
was corroborated in mobility shift experiments using in-would have been present in a complex with E1A. Be-
cause of the difficulties of demonstrating an interaction fected cell extracts. No p107-containing E2F complexes
were identified in wt-infected cells, whereas they werein radiolabeled infected cells by coimmunoprecipitation,
we used two other experimental approaches to confirm readily seen in mock-infected cells (Fig. 7 and data not
shown). We infer that this is because in infected cellsthe in vitro results.
Use of MAV-1 mutant viruses with deletions in the p107 is complexed with E1A. In the CR2D and TTG mu-
tants that were unable to produce E1A that could associ-E1A region demonstrated that the same E1A regions that
were required in vitro were required for association with ate with p107 (Fig. 5), p107–E2F complexes were seen
in mobility shift experiments (Fig. 7). This is consistentboth mouse pRb and mouse p107 in coimmunoprecipita-
tion experiments using infected cell extracts (Figs. 4 and with some p107 not complexing with E1A and therefore
being available for binding to E2F. This result provides5). Both pRb and p107 were coimmunoprecipitated from
dlE106-infected cells which express a CR3D mutant E1A genetic evidence for the assertion that wt MAV-1 E1A
associates with p107 and that CR2 is essential for thisprotein (55 and 83% of wild-type, respectively). Neither
pRb nor p107 was coimmunoprecipitated from mock or association.
The requirement for E1A CR1 and CR3 for binding topmE109 (TTG)-infected cells which did not have E1A in
the lysates. Little or no pRb was coimmunoprecipitated p107 was not resolved in these experiments. CR1 and
CR3 were less important than CR2, since p107 was foundfrom dlE105 (CR1D)- or dlE102 (CR2D)-infected cells (4
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Genome organization of mouse adenovirus type 1 early region 1: Ato associate with CR1D and CR3D mutants. The coim-
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